Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.66% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NAGE · Sep 30, 2024
Niagen Bioscience, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-24-044540General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
31.21% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
41.22% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
63.49% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
6.26% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.04% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.87% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History17 statesSelf-history eligible
Jun 30, 20220/6 normalizedLevel 3Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20246/7 normalizedLevel 3Sep 30, 20246/7 normalizedLevel 3Dec 31, 20246/7 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -1.16%
- Current
- 13.66%
- Delta
- 14.82%
- Previous
- 11.89%
- Current
- 31.21%
- Delta
- 19.33%
- Previous
- 50.62%
- Current
- 41.22%
- Delta
- -9.40%
- Previous
- 60.22%
- Current
- 63.49%
- Delta
- 3.27%
- Previous
- -1.13%
- Current
- 6.26%
- Delta
- 7.39%
- Previous
- 5.79%
- Current
- 5.04%
- Delta
- -0.74%
- Previous
- 5.21%
- Current
- 2.87%
- Delta
- -2.34%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NAGE Fundamental State →Has State · Niagen Bioscience, Inc. →Transitioned To · NAGE Fundamental State →Transitioned To · NAGE CASH_GENERATION_INCREASED →Transitioned To · NAGE GROWTH_INCREASED →Transitioned To · NAGE INVENTORY_PRESSURE_DECREASED →Transitioned To · NAGE MARGIN_INCREASED →Transitioned To · NAGE PROFITABILITY_INCREASED →Transitioned To · NAGE R_AND_D_INTENSITY_DECREASED →Transitioned To · NAGE SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.